Literature DB >> 3197285

Activities of creatine kinase and its isoenzymes in serum in various skeletal muscle disorders.

J Arenas1, V Diaz, G Liras, E Gutierrez, I Santos, A Martinez, J M Culebras.   

Abstract

We studied possible correlations between anatomopathological and clinical features and the values for total creatine kinase (CK; EC 2.7.3.2) and its isoenzymes, including the proportion of CK-MB, in a population displaying several neuromuscular pathologies. Although we observed no specific isoenzyme pattern associated with the different myopathies, we found isoenzyme analysis useful in studying the histopathological evolution of illness. We also considered whether the pathology was regenerative or nonregenerative, and what type of fiber (I or II) was involved. High CK-MB percentages (greater than 6%) were associated with regenerative and type I fiber myopathies, with regenerative type tissues being the principal factor associated with an increasing proportion of CK-MB. Studying the changes in CK-MB percentage in serum appears to be useful in discriminating neuromuscular from myocardial pathologies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197285

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).

Authors:  Stuart J Moat; Donald M Bradley; Rachel Salmon; Angus Clarke; Louise Hartley
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

2.  Biochemical markers of myocardial injury.

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2007-03

3.  Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups.

Authors:  Rita Volochayev; Gyorgy Csako; Robert Wesley; Lisa G Rider; Frederick W Miller
Journal:  Open Rheumatol J       Date:  2012-06-01

4.  Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy.

Authors:  Sunju Park; Breanne Maloney; Michele Caggana; Norma P Tavakoli
Journal:  Muscle Nerve       Date:  2022-04-06       Impact factor: 3.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.